FDA Registration and U.S. Agent After an Acquisition or Owner Change

Introduction

An acquisition does not produce one universal FDA registration result. The controlling facts are which legal entity becomes the owner or operator, whether manufacturing remains at the same physical establishment, which FDA registration system applies, and which product records point back to that establishment.

Food facilities require cancellation by the former owner and a new registration by the buyer. Medical device facilities use an FDA ownership-transfer workflow. Drug establishments must move from the seller's registration SPL to the acquiring registrant's SPL. Cosmetics require changed owner, operator, facility, and U.S. Agent information to be amended within 60 days, but the MoCRA filing framework does not create a separate automatic-transfer rule.

This matters most to regulatory, quality, and operations leads coordinating a closing, integrating an acquired facility, or preparing the first U.S. shipment after a transaction. The deal name is not the filing trigger. The regulated identity that changed is.

FDA ownership-change matrix across the four verticals

What an acquisition changes in each FDA registration system
Vertical	Registration outcome	Reporting deadline	Registration number or FEI	U.S. Agent and downstream records
Food and beverage	A new legal owner cannot take over the former owner's food facility registration. The former owner cancels, and the new owner submits a new registration.	The former owner must cancel within 60 calendar days. Other changes, including operator, agent in charge, address, and U.S. Agent information, must be updated within 60 calendar days. 21 CFR 1.234	The former registration number does not transfer to the new owner. The buyer can identify the previous registration during re-registration so FDA can connect and cancel the old record. FDA food registration field guide	The new or changed U.S. Agent must accept the designation when FDA verification applies. Food facility registration does not create product-level FDA listings, but product categories, Prior Notice responsibilities, and FSVP arrangements should be reviewed separately.
Cosmetics	Required registration information, including the owner or operator and foreign facility U.S. Agent, is handled through a facility registration amendment. A genuinely new manufacturing location follows the initial-registration rule.	Changes to required facility registration information must be reported within 60 days. A new facility must register within 60 days after first engaging in covered manufacturing or processing. 21 U.S.C. 364c	The facility registration number is its FEI. Use the FEI that correctly identifies the acquired physical facility rather than treating an FEI as proof that the buyer's registration obligations transferred automatically.	Update the U.S. Agent, brand names, product categories, and responsible-person data when those fields change. Cosmetic product listings are maintained by the Responsible Person and must be updated annually if the Responsible Person, facility FEI, ingredients, or other listing data changes. FDA Form 5066 instructions
Medical devices	The buyer records the purchase through the Device Registration and Listing Module's transfer-of-ownership workflow. The process is not automatic and requires the buyer to review facility activities and associated device listings.	Registration information changes must be filed within 30 days. Changes to a foreign establishment's U.S. Agent name, address, or phone number must be reported within 10 business days. 21 CFR 807.22	The buyer enters the acquired facility's existing registration number to begin the transfer workflow. The registration number identifies the facility being purchased, while the acquiring owner or operator completes the new registration relationship and current fee process.	The buyer must select the products and activities that remain associated with the acquired facility. A foreign establishment must also designate one U.S. Agent under 21 CFR 807.40.
Drugs and pharmaceuticals	The acquired establishment should be removed from the former registrant's establishment registration SPL and added to the acquiring company's registration SPL. This is a coordinated seller-and-buyer filing sequence, not an assumed transfer.	A sale, closure, name change, physical-address change, or U.S. Agent contact change must be reported within 30 calendar days. Foreign establishments must be registered before covered drugs are imported or offered for import. 21 CFR 207.29	The DUNS and FEI may remain the same or change, depending on how FDA resolves the establishment identity after the transaction. FDA's registration SPL records must still link the establishment to the correct acquiring registrant. FDA establishment registration highlights	Only the registrant can designate a new U.S. Agent. Labeler codes can transfer through a merger or acquisition, but labeler-code information must be updated within 30 days and affected product listings must carry the new labeler name. FDA labeler-code instructions

The deal structure determines the filing path

When the legal registrant remains the same

A purchase of shares or a change in the parent company's ownership does not necessarily replace the legal entity identified as the FDA owner or operator. If that registered entity, the physical establishment, and its regulated activities remain unchanged, the transaction may require targeted amendments rather than a new registration.

The diligence team should still compare every required field against the post-closing structure. A surviving legal entity can retain its name while its official contact, corporate officers, U.S. Agent, parent information, product portfolio, or operating activities change.

When a different entity acquires the facility

An asset purchase or facility sale usually creates the sharper registration issue because a different legal person becomes responsible for the regulated operation. Food requires cancellation and re-registration. Devices use the DRLM purchase workflow. Drugs require the establishment to move between registration SPLs. Cosmetics require the owner or operator information to be amended and the FEI identity checked against the acquired site.

When manufacturing moves to another physical site

A new physical establishment should not be treated as a routine mailing-address correction. Determine whether the original site remains operational, whether the new site performs regulated activities, and whether both locations require active records during the transition.

New-site timing differs by vertical. A new food owner must register before operating the acquired facility for U.S. consumption. New cosmetic facilities generally have 60 days after first engaging in covered activity. Device establishments generally register within 30 days after beginning a covered operation, while foreign drug establishments must register before their products are imported or offered for import.

Does FDA notify you when a U.S. Agent listing becomes invalid?

No universal invalid-agent alert exists across FDA systems. FDA may send notifications during a new or updated agent-confirmation workflow, but companies should not rely on FDA to detect that a commercial agent agreement expired, that an agent stopped responding, or that contact details became obsolete.

Food facility registrations

FDA normally contacts the person identified as the U.S. Agent when verification is required. If the proposed agent reports that it did not agree to serve, FDA informs the facility and requests an amendment. If the agent does not respond within 30 calendar days, the pending registration, renewal, or update submission can be removed, requiring a new submission. FDA food facility registration guidance

Medical device establishments

CDRH sends the identified U.S. Agent a confirmation request. If confirmation is not received within 10 business days, CDRH informs the foreign establishment and asks it to amend the registration with an agent that has agreed to serve. This confirmation protects the designation process, but it is not continuing surveillance of the commercial relationship. FDA device U.S. Agent confirmation instructions

Drug and cosmetic establishments

Drug registrants must update changed U.S. Agent information within 30 days, and only the registrant can designate the replacement. Cosmetic facility registration information, including the foreign facility's U.S. Agent contact, must be amended within 60 days. The published rules do not establish a general notification service that alerts the manufacturer whenever its agent relationship privately terminates.

How a company should verify the designation

Obtain the incoming agent's written acceptance before submitting the change.
Keep the facility-controlled FDA account and official-contact email active through closing.
Review the final accepted registration record rather than relying only on a submission receipt.
Require the agent to identify who monitors FDA correspondence and how urgent messages are escalated.
Include U.S. Agent continuity in the transaction closing checklist and post-closing compliance calendar.

Registration is only the first transaction workstream

Food records

A new food facility registration does not by itself resolve shipment-level or importer responsibilities. Confirm that product categories remain accurate and separately review Prior Notice, FSVP importer arrangements, customs data, emergency contacts, and DUNS or UFI alignment. The distinction between the facility's U.S. Agent and the FSVP importer remains unchanged by the acquisition. The FSVP Importer vs FDA U.S. Agent guide explains those separate roles.

Cosmetic product listings

A facility amendment does not automatically update each cosmetic product listing. The Responsible Person should review the facility FEI, label name, contact details, formulation, product category, and manufacturing locations in every affected listing. Product listing updates are required annually, but transaction teams should correct acquisition-related inconsistencies before relying on the listings for continued U.S. distribution.

Device listings

The DRLM ownership-transfer workflow asks the buyer to identify previously associated products and the activities performed at the acquired facility. That review is substantive. The new owner should confirm product codes, proprietary names, establishment activities, importers, premarket submission references, and any separate UDI or GUDID records affected by changes to the labeler or company identity.

Drug SPLs, listings, and labeler codes

Drug establishment registration, product listing, and labeler-code records are separate SPL submissions. The former registrant must release the acquired establishment from its registration SPL before the acquiring registrant links it to a new SPL record. Drug listings must be reviewed each June and December at minimum, while material changes and labeler-code ownership data should be updated on the applicable schedule. 21 CFR 207.57

Where acquisition integrations break

Treating every deal as a transfer: Food registration expressly does not transfer to a new owner, while devices provide a structured purchase workflow.
Equating FEI continuity with registration continuity: An FEI identifies an establishment, but the correct registrant, owner or operator, agent, and product relationships must still be filed.
Changing the agent contract without changing the FDA record: Commercial appointment and FDA-system designation are separate actions.
Updating the facility but not the products: Cosmetic product listings, device listings, and drug SPL records can remain linked to outdated entities or facilities after the establishment filing is complete.
Waiting for annual renewal: Ownership, sale, address, and U.S. Agent changes often have 10-business-day, 30-day, or 60-day reporting deadlines that apply before the next renewal window.
Losing access to the seller's records: Registration numbers, FEIs, DUNS data, SPL set IDs, device listing numbers, confirmation records, and FDA account access should be collected before closing.

Post-acquisition FDA filing checklist

Inventory every regulated establishment. Record its legal name, physical location, FDA system, registration number, FEI, UFI or DUNS number, owner or operator, official contact, U.S. Agent, and renewal date.
Map the legal change. Document whether the transaction changes the parent company only, the registered owner or operator, the facility location, or the entity conducting regulated activities.
Classify the required action by vertical. Choose cancellation and new registration, amendment, DRLM ownership transfer, or movement between drug registration SPLs.
Sequence seller and buyer filings. Coordinate food cancellation, drug deregistration or removal, buyer registration, and agent designation so operations and imports are not left between records.
Confirm U.S. Agent acceptance. Verify the correct agent appears in the final record and that all FDA confirmation requests were completed.
Reconcile product records. Review cosmetic listings, device listings, drug SPLs, labeler codes, NDCs, and other product identifiers linked to the acquired establishment.
Preserve evidence. Retain accepted submissions, confirmation pages, database records, agent acceptance, transaction authority, and a post-closing compliance calendar.

Where FDA Entry Point fits in an ownership transition

FDA Entry Point is a strong fit when a foreign manufacturer needs the U.S. Agent designation coordinated with registration amendments, new-owner filings, product listings, and renewal tracking rather than handled as a stand-alone contact change. This is especially useful when an acquisition covers more than one FDA vertical or the buyer has no dedicated U.S. regulatory operations team.

The work can include building the registration inventory, identifying the correct filing path, coordinating the outgoing and incoming entities, updating U.S. Agent information, filing facility or establishment records, reconciling product listings, and supporting drug SPL or device-listing submissions. FDA Entry Point operates across food and beverage, cosmetics, medical devices, and drugs under one compliance process. FDA Entry Point compliance process

Registration work should be coordinated with transaction counsel and the relevant submission owners when the deal also transfers marketing applications, premarket authorizations, quality agreements, state licenses, or other regulatory assets outside the establishment-registration systems.

Frequently asked questions

Does an FDA registration transfer automatically if my company is acquired?

No FDA registration should be assumed to transfer automatically after an acquisition. Food requires the former owner to cancel and the buyer to register again. Devices use a specific DRLM transfer-of-ownership workflow. Drug establishments move between the seller's and buyer's registration SPLs. Cosmetics require an amendment to changed registration information, with the facility FEI checked against the post-closing entity and location.

Do I need to re-register with FDA after a change in company ownership?

Food facilities need a new registration when the legal owner changes. Medical device buyers report the purchase through DRLM rather than creating an unrelated duplicate facility record. Drug buyers link the establishment to the acquiring registrant's SPL. Cosmetic facilities amend changed owner or operator information within 60 days. A parent-company or shareholder change may produce a different result if the registered legal entity remains unchanged.

Can an acquired facility keep the same FEI?

An FEI may remain associated with the same physical establishment, but FEI continuity does not settle the registration question. FDA notes that DUNS and FEI values may remain the same or change during drug mergers and acquisitions. Device transfers begin with the acquired facility's existing registration number, while food assigns the new owner a new registration. Cosmetic filings must use the FEI that correctly identifies the registered facility.

What FDA filings are needed when a manufacturing facility changes hands?

The filing package normally includes the establishment action, U.S. Agent and official-contact updates, and reconciliation of product records. Depending on the vertical, this means food cancellation and re-registration, a device DRLM purchase transfer, a cosmetic registration amendment, or removal and addition of the drug establishment across registration SPLs. Cosmetic product listings, device listings, drug SPLs, and labeler-code records should then be reviewed separately.

Does FDA notify me if my U.S. Agent listing becomes invalid?

FDA does not provide one universal notification when a U.S. Agent relationship becomes invalid. Food and device systems send confirmation requests during certain new or updated designations and may contact the facility when confirmation fails. Drug and cosmetic registrants remain responsible for keeping agent information current. Companies should monitor the registered contact emails and verify the final FDA record after any agent change.

What happens to my FDA registration if my U.S. Agent resigns?

The registration does not automatically move to another agent. The foreign establishment must designate a replacement and update the applicable FDA system within the vertical's deadline. Food and cosmetic changes generally carry a 60-day update period, drug agent information changes carry a 30-day period, and device agent contact changes must be reported within 10 business days. The replacement should complete any FDA acceptance or confirmation step promptly.